NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Open Posted
- Opportunity number
- PAR-25-141
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Independent School Districts
- Public or Indian Housing Auth.
- For Profit Organizations
- Small Businesses
- Higher Education Inst. (Private)
- Special District Governments
- Tribal Governments (Federally Recognized)
- Tribal Organizations (Not Federally Recognized)
- County Governments
- City/Township Governments
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Non-501(c)(3) Nonprofits
- Other
- State Governments
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health is soliciting applications for the NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required), with an application due date of March 4, 2027. This funding opportunity requires applicants to conduct a clinical trial as a mandatory component of the award.
Eligible applicants include higher education institutions (public and private), 501(c)(3) and non-501(c)(3) nonprofits, for-profit organizations, small businesses, state and local governments, county and city/township governments, special district governments, tribal governments (federally recognized and not federally recognized), tribal organizations, independent school districts, and public or Indian housing authorities. Additional eligible applicants include historically Black colleges and universities, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, Asian American Native American Pacific Islander serving institutions, tribally controlled colleges and universities, regional organizations, faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions. Non-domestic (non-U.S.) entities are not eligible; however, foreign components of U.S. organizations are permitted.
The program is assigned CFDA 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, and operates under the National Institute of Arthritis and Musculoskeletal and Skin Diseases mission to advance research into the causes, treatment, and prevention of arthritis, musculoskeletal, and skin diseases, including training of basic and clinical scientists in these fields.
This announcement is a reissue of PAR-24-208 with modifications only to Section V (Application Review Information) to align with NIH's Simplified Review process for research project grant applications.
Synopsis
This NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR, a re-issue of PAR-24-208, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V. Application Review Information of the funding opportunity are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-141-Full-Announcement.html | HTML file | |
| PKG00289530.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity